The IDEXX Conundrum: A Cautionary Tale of Tech and Trust IDEXX Laboratories, valued at $50.
7 billion, has struggled to keep pace with the broader market over the past 52 weeks, with its stock declining by a significant 14. 2%. This is in stark contrast to the S&P 500 Index's 18.
7% return over the same period. The discrepancy between IDEXX's underperformance and the overall market raises important questions about the factors driving this trend.